CYTK EPS Estimates
Cytokinetics, Incorporated
$63.95
+$1.30(+2.08%)
33
Overall
40
Value
18
Tech
42
Quality
Market Cap
$8.89B
Volume
1.05M
52W Range
$54.30 - $88.31
Target Price
$107.33
CYTK EPS estimates: the consensus estimate for Cytokinetics, Incorporated's current fiscal year is -$5.97 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
CYTK EPS Estimates
- EPS estimate, current quarter
- $-1.52
- EPS estimate, next quarter
- $-1.51
- EPS estimate, current year
- $-5.97
- EPS estimate, next year
- $-4.53
- EPS growth, 3-year
- -14.74%
| Fiscal year | EPS |
|---|---|
| 2025 | $-6.54 |
| 2024 | $-5.26 |
| 2023 | $-5.45 |
| 2022 | $-4.33 |
| 2021 | $-2.80 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CYTK | $63.95 | +2.1% | 1.05M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cytokinetics, Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW